Antibe Therapeutics Inc.
TSX:ATE.TO
0.295 (CAD) • At close April 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -19.475 | -25.06 | -24.734 | -19.342 | -12.816 | -7.43 | -5.746 | -2.631 | -4.401 | -2.68 | -1.045 | -0.942 |
| Depreciation & Amortization
| 0 | 0.099 | 0.478 | 0.572 | 0.416 | 0.377 | 0.353 | 0.161 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0.452 | 1.6 | 0 | -0.31 | -0.298 | -0.865 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 2.808 | 5.521 | 3.989 | 3.376 | 0 | 0.693 | 1.156 | 0.515 | 0.292 | 0.185 | 0.124 | 0 |
| Change In Working Capital
| 0.028 | 2.502 | 19.659 | 1.691 | 2.226 | -0.476 | 0.425 | -0.226 | 0.314 | -0.452 | 0.413 | 0.717 |
| Accounts Receivables
| 0 | 0.287 | -1.356 | -0.039 | -0.186 | -0.062 | 0.202 | -0.153 | 0 | 0 | 0 | 0 |
| Inventory
| -0.239 | -0.099 | 0.53 | -0.621 | 0.303 | -0.353 | -0.379 | 0.467 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.217 | 0.927 | -4.746 | 2.541 | 0.791 | -0.1 | 0 | -0.532 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0.484 | 1.387 | 25.231 | -0.19 | 1.318 | 0.039 | 0.602 | -0.008 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| 0.334 | 0.018 | 0.052 | 0.168 | 0.131 | 0.695 | 0.671 | 0.276 | 0 | 0.015 | 0.026 | 0 |
| Operating Cash Flow
| -16.305 | -16.92 | -0.105 | -11.935 | -7.056 | -6.451 | -3.44 | -2.77 | -3.796 | -2.932 | -0.481 | -0.225 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0.009 | -0.009 | 0 | -0.002 | -0.157 | -0.051 | -0.257 | -0.289 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0.319 | -0.236 | 0 | 0 | 0 | 0 | 0 | -0.4 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -48.436 | -19.975 | 0 | 0 | -0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 36.299 | 0.02 | 0 | 0.1 | 0 | 0 | 0 | 0 | 0.625 | 0 | 0 | 0 |
| Other Investing Activites
| -0.012 | -0.02 | -0.264 | -0.56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -11.827 | -20.22 | -0.264 | 0.098 | -0.257 | -0.051 | -0.257 | -0.689 | 0.625 | 0 | 0 | 0 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -0.079 | -0.152 | -2.41 | -0.192 | -1.291 | 0 | -0.392 | -0.048 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0.128 | 69.115 | 8.05 | 5.929 | 0 | 4.179 | 1.225 | 1.045 | 7.643 | 0.085 | 0.411 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.159 | -0.002 | -0.545 | 4.145 | 4.949 | 0.009 | 1.019 | 2.271 | -0.582 | -1.151 | 0.497 | -0.097 |
| Financing Cash Flow
| 0.08 | -0.026 | 66.16 | 12.003 | 9.587 | 0.009 | 4.806 | 3.448 | 0.463 | 6.492 | 0.582 | 0.315 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 28.024 | 37.129 | -65.725 | 0.023 | -0.007 | -0.027 | 0.007 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -28.052 | -37.166 | 65.791 | 0.189 | 2.267 | 2.224 | 1.116 | -0.011 | -2.708 | 3.561 | 0.101 | 0.089 |
| Cash At End Of Period
| 6.755 | 34.807 | 71.973 | 6.182 | 5.993 | 3.726 | 1.502 | 0.386 | 0.397 | 3.755 | 0.194 | 0.093 |